Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Osteopore Ltd. ( (AU:OSX) ) has shared an announcement.
Osteopore Limited has issued a cleansing notice in connection with a new $250,000 sub‑tranche (ST18 of T1) of redeemable convertible notes subscribed for by Advance Opportunities Fund and Advance Opportunities Fund I under an existing subscription agreement of up to $20 million. The notice confirms that these Sixth Convertible Notes will be issued without a prospectus, and that ordinary shares issued upon their conversion can be freely on‑sold to retail investors, reflecting the company’s continued use of staged convertible note funding to support its capital needs while maintaining compliance with Australian corporate and ASX disclosure requirements.
The most recent analyst rating on (AU:OSX) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Osteopore Ltd. stock, see the AU:OSX Stock Forecast page.
More about Osteopore Ltd.
Osteopore Limited (ASX: OSX) is a medical technology company that develops and commercialises regenerative implants, with its shares listed on the Australian Securities Exchange and capital management supported through institutional funding arrangements such as convertible note programs.
Average Trading Volume: 1,429,536
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$3.11M
For a thorough assessment of OSX stock, go to TipRanks’ Stock Analysis page.